Insider · CIK 0001779466
John Goll
Files at IMCR (Immunocore Holdings plc). First filing Feb 19, 2026, latest Feb 19, 2026.
In brief
John Goll files SEC Form 4 as officer at IMCR (Immunocore Holdings plc). Since Feb 19, 2026, John Goll has reported 0 open-market buys worth $0 and 1 open-market sell worth $23k, the latest filed on Feb 19, 2026.
A track record needs three past buys with six months of prices behind them; John Goll has 0, so none is measured yet.
The newest scored trade: sold $23k of IMCR on Feb 18, 2026, filed Feb 19, 2026, scored 35 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $23k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMCR: Immunocore Holdings plc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Immunocore Holdings plc | $23k 698 shares | -52% | +33% from low-19% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares | +1,351 | $0.00 | $0 | 1,351 | Feb 19, 2026 |
| Feb 18, 2026 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares | -698 | $32.35 | $23k | 653 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | MOption exercise Restricted Share Unitsderivative | -1,351 | $0.00 | $0 | 4,054 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | AGrant or award Restricted Share Unitsderivative | +7,411 | $0.00 | $0 | 7,411 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +21,252 | $0.00 | $0 | 21,252 | Feb 19, 2026 |
| Feb 17, 2025 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +14,802 | $0.00 | $0 | 14,802 | Feb 19, 2025 |
| Feb 17, 2025 | IMCR Immunocore Holdings plc | AGrant or award Restricted Share Unitsderivative | +5,405 | $0.00 | $0 | 5,405 | Feb 19, 2025 |
Questions about John Goll
Answered from the filings on this page, as of the latest one.
Is John Goll buying or selling?
In the last 12 months John Goll reported 0 open-market buys worth $0 and 1 open-market sell worth $23k on SEC Form 4; the latest was sold $23k of IMCR on Feb 18, 2026. Grants, option exercises and tax withholding are not counted.
How did John Goll's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Goll has 0.
Where does John Goll file Form 4?
John Goll has filed Form 4 at IMCR (Immunocore Holdings plc) as SVP, FINANCE & CAO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.